Details for New Drug Application (NDA): 019643
NDA 019643 describes MEVACOR, which is a drug marketed by Merck and is included in one NDA. Additional details are available on the MEVACOR profile page.
The generic ingredient in MEVACOR is lovastatin. There is one drug master file entry for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the lovastatin profile page.
The generic ingredient in MEVACOR is lovastatin. There is one drug master file entry for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the lovastatin profile page.
Summary for 019643
| Tradename: | MEVACOR |
| Applicant: | Merck |
| Ingredient: | lovastatin |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 019643
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Mar 28, 1991 | TE: | RLD: | Yes | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 20MG **Federal Register notice that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Aug 31, 1987 | TE: | RLD: | Yes | |||||
Profile for product number 004
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 40MG **Federal Register notice that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Dec 14, 1988 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
